Navigation Links
New Surgical Options for Breast Cancer Patients!
Date:10/16/2007

SAN FRANCISCO, Oct. 16 /PRNewswire/ -- According to the American Cancer Society, over 200,000 new breast cancer cases are diagnosed annually in the United States. Also, a recent article suggests that more than forty percent of women who undergo breast cancer removal are not offered any type of reconstruction, referred to a surgeon, or educated in any way on current reconstructive options available.

Dr. Gabriel Kind, M.D., FACS, is a board certified plastic surgeon who practices in San Francisco, California and specializes in breast reconstruction before and after the diagnosis of breast cancer. Dr. Kind offers a variety of surgical options to help breast cancer patients and survivors recover gracefully from this disease!

"As a surgeon, I always educate my patients as to all of their options when dealing with something as serious as mastectomy surgery to remove cancer," says Dr. Kind. "Many options are available. What appears to be the procedure of choice for many women is the DIEP flap, or Deep Inferior Epigastric Perforator flap. Spreading the word about the options women have is the key to recovery."

With the DIEP procedure, Dr. Kind begins by harvesting tissue from a patient's lower abdomen and uses the fat, skin and DIEP vessels that supply necessary blood, and successfully recreates a natural-looking new breast for his patient. Since the abdominal wall tissue is similar to breast tissue, it produces a natural, aesthetically pleasing result without the use of an implant, and no sacrifice of muscle resulting in less post-surgical pain and complications.

The DIEP procedure has the advantage of avoiding implants, which can leak or rupture, requiring replacement, implants usually do poorly in patients who have had or will have radiation therapy for cancer. The DIEP brings healthy tissue to irradiated areas.

Dr. Kind has performed more DIEP procedures than any other surgeon in the Bay Area, and according to Dr. Kind, there are three main types of patients who receive the DIEP procedure: Newly found breast cancer patients; patients who had breast cancer removal and opted for breast implants and are having complications; and patients who have had mastectomy surgery to remove cancer, but had no breast reconstruction afterward. For these three types of women the DIEP procedure is a remarkable option.

"Reconstructive breast surgery is a sensitive topic amongst breast cancer patients, but the DIEP procedure is a significant step forward, offering another option for women facing breast cancer surgery," states Dr. Kind. "I believe that excellence in surgery and the compassionate care and education of patients must go hand-in-hand."

Dr. Gabriel Kind, M.D., FACS received his undergraduate degree from Dartmouth College, and attended Northwestern University Medical School. Additionally, Dr. Kind was fully trained in General Surgery at Rush Presbyterian St.Luke's Medical Center, and Plastic and Reconstructive Surgery at Northwestern University, McGaw Medical Center. He also completed a fellowship in Hand and Microsurgery at the Davies Medical Center which is now part of California-Pacific Medical Center in San Francisco. Dr. Kind was Board Certified by the American Board of Surgery, by the American Board of Plastic Surgery, and received a Certificate of Added Qualification in Surgery of the Hand from the American Board of Surgery. Dr. Kind is a member of the American Society of Plastic Surgeons, the American Association of Plastic Surgeons, and the American Society for Reconstructive Microsurgery, as well as several other national medical organizations. Dr. Kind is an Assistant Clinical Professor in the Department of Surgery, Division of Plastic and Reconstructive Surgery, at the University of California-San Francisco. Visit http://www.drkind.com


'/>"/>
SOURCE The Professional Image, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Indonesian boy with huge neck tumor was surgically removed
2. New spray gel heals surgical wounds
3. FDA approves surgical gel
4. Lower surgical volume linked to higher death rate
5. Sleep apnoea linked to surgical risks
6. Treatment Of Brain Aneurysms By A New Non-Surgical Approach
7. Complete Robotic Surgery To Revolutionize Surgical Treatment of Prostate Cancer
8. Surgeon Attempts to Create A Surgical Hernia Feat
9. Researchers Aim To Develop Next Generation Of Surgical Robots
10. Arrow Embedded In Tribal’s Chest For Two Weeks Surgically Remove
11. Surgical Intervention to Solve Obesity and Related Problems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... 2017 , ... The Center for Autism and Related Disorders ... Research and Treatment (RI-CART) and Cinemaworld to present Sensory Friendly Films. The events ... films in an environment that accommodates their unique needs. , Launched in January, ...
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/22/2017)... ... February 22, 2017 , ... When it came ... contact center in Georgia, PENETRON Specialty Products (PSP) provided the solution. January’s grand ... recently invested $51 million to purchase and renovate the 185,000 square-foot office complex, ...
(Date:2/22/2017)... , ... February 22, 2017 , ... The Waismann ... the thousands of individuals who have recently fallen victim to America’s opioid epidemic. Now, ... Orange County, California, where they are free from the shame, stigma, and harmful ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... to fewer trips the emergency room, fewer hospital admissions, and better blood pressure ... Managed Care® (AJMC®) finds. The study can be found here . , ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... DUBLIN , Feb 23, 2017 Research ... Prosthetic Devices Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 9.2% over the next ... industry report analyzes the market estimates and forecasts for all the ...
(Date:2/23/2017)... 23, 2017 MabVax Therapeutics Holdings, ... development company, announces that it has received notice ... authorizing the initiation a Phase I clinical trial ... cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is the Company,s ... to initiate the phase I clinical trial in ...
(Date:2/23/2017)... , Feb. 22, 2017 Orthopedic ... implant demand, as aging demographic patterns lead to ... Implants for sports- and exercise-related injuries, chronic back ... will lead sales gains. The future of medical ... addresses the following questions and more: - ...
Breaking Medicine Technology: